Impact of nonalcoholic fatty liver disease on the risk of metachronous colorectal neoplasia after polypectomy
Nam Hee Kim, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Chong Il Sohn
Korean J Intern Med. 2021;36(3):557-567. Published online 2020 Jul 7 DOI: https://doi.org/10.3904/kjim.2019.360
Citations to this article as recorded by 
Comorbidities related to metachronous recurrence for early gastric cancer in elderly patients
Ying Xiang, Ying Yuan, Zhen-Yu Wang, Yan-Mei Zhu, Wen-Ying Li, Qian-Ge Ye, Ya-Nan Wang, Qi Sun, Xi-Wei Ding, Faraz Longi, De-Hua Tang, Gui-Fang Xu
World Journal of Gastrointestinal Endoscopy.2025;[Epub] CrossRef
MASLD: Prevalence, Mechanisms, and Sex-Based Therapies in Postmenopausal Women
Ilaria Milani, Marianna Chinucci, Frida Leonetti, Danila Capoccia
Biomedicines.2025; 13(4): 855. CrossRef
Established nomogram based on clinicopathological characteristics, lifestyle, and comorbidities risk factors for metachronous recurrence in curative endoscopic submucosal dissection
Ying Xiang, Zhenyu Wang, Yichun Ma, Ying Yuan, Wenying Li, Yanmei Zhu, Qiange Ye, Yanan Wang, Jinping Yang, Qi Sun, Xiwei Ding, Faraz Longi, Dehua Tang, Fangmei An, Guifang Xu
Therapeutic Advances in Gastroenterology.2025;[Epub] CrossRef
Metabolic Dysfunction-Associated Steatotic Liver Disease in the Korean General Population: Epidemiology, Risk Factors, and Non-Invasive Screening
Yong Jun Choi, Jooheon Park, Han-Ik Cho, Myung Geun Shin, Eun-Hee Nah
Metabolites.2025; 15(5): 299. CrossRef
Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies
Kai En Chan, Elden Yen Hng Ong, Charlotte Hui Chung, Christen En Ya Ong, Benjamin Koh, Darren Jun Hao Tan, Wen Hui Lim, Jie Ning Yong, Jieling Xiao, Zhen Yu Wong, Nicholas Syn, Apichat Kaewdech, Margaret Teng, Jiong-Wei Wang, Nicholas Chew, Dan Yock Young
Clinical Gastroenterology and Hepatology.2024; 22(3): 488. CrossRef
Association of MASLD with the risk of extrahepatic cancers: A systematic review and meta‐analysis of 18 cohort studies
Ben‐Gang Zhou, Xin Jiang, Qiang She, Yan‐Bing Ding
European Journal of Clinical Investigation.2024;[Epub] CrossRef
Association between metabolic dysfunction-associated steatotic liver disease and risk of colorectal cancer or colorectal adenoma: an updated meta-analysis of cohort studies
Jian-Feng Zhao, Ben-Gang Zhou, Yang Lv, Qiu-Ping Teng, Xi-Mei Wang, Xiao-Yi Li, Yi Ding
Frontiers in Oncology.2024;[Epub] CrossRef
Metabolic‐associated fatty liver disease is associated with colorectal adenomas in young and older Korean adults
Jiwon Chang, Yoosoo Chang, Yoosun Cho, Hyun‐Suk Jung, Dong‐Il Park, Soo‐Kyung Park, Soo‐Youn Ham, Sarah H. Wild, Christopher D. Byrne, Seungho Ryu
Liver International.2023; 43(11): 2548. CrossRef
Non-Alcoholic Fatty Liver Disease and Extrahepatic Cancers: A Wolf in Sheep’s Clothing?
Athanasia Mitsala, Christos Tsalikidis, Konstantinos Romanidis, Michail Pitiakoudis
Current Oncology.2022; 29(7): 4478. CrossRef
Analysis of the correlation between non-alcoholic fatty liver disease and the risk of colorectal neoplasms
Shujun Ye, Yang Liu, Te Zhang, Huijin Feng, Yanqing Liu, Lianjun Ma
Frontiers in Pharmacology.2022;[Epub] CrossRef